Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab + Paclitaxel/nab-Paclitaxel in Relapsed ES-SCLC
NCT04056949Phase 2Unknown
- Start
- Aug 2019
- Primary completion
- Feb 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in small cell lung cancer (SCLC). Status: unknown.
02
Drugs
sintilimab
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT04056949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04056949.